Successfully reported this slideshow.
DR HUGO
STEPHENSON
iGuard
Challenge - October 2007

 – Improve medication safety for patients
 – Build a community of patients for clinical research...
iGuard.org is…
– The largest medication monitoring service
– The largest patient-centric research platform
               ...
iGuard.org users get…

– FREE medication safety checks
– RAPID medication safety alerts and recalls
– ACCESS to feedback f...
iGuard.org details…

– Longitudinal TSQM data from >300,000 patients
– “Registries” for 100s products / conditions



– Da...
Patients join by…

– REFERRAL through Quintiles’ partner sites
– OUTREACH in Quintiles’ clinical clusters
– REFERRAL thoug...
Rapid Access to Targeted Patients




                              Feb 10:   UK
                              Oct 10:   F...
Improving Research Efficiency
Observational Research
– Patient centric studies that collect observational data from patients,
  physicians, and local la...
For More Information, Please Contact
      hugo.stephenson@iGuard.org
How iGuard Connects with 2.6 Million e-Patients
Upcoming SlideShare
Loading in …5
×

How iGuard Connects with 2.6 Million e-Patients

933 views

Published on

Hugo Stephenson, MD, iGuard

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

How iGuard Connects with 2.6 Million e-Patients

  1. 1. DR HUGO STEPHENSON iGuard
  2. 2. Challenge - October 2007 – Improve medication safety for patients – Build a community of patients for clinical research heavy touch ? light touch disease specific general
  3. 3. iGuard.org is… – The largest medication monitoring service – The largest patient-centric research platform …in the world 2.4M Oct 07 Sep 10
  4. 4. iGuard.org users get… – FREE medication safety checks – RAPID medication safety alerts and recalls – ACCESS to feedback from thousands of patients
  5. 5. iGuard.org details… – Longitudinal TSQM data from >300,000 patients – “Registries” for 100s products / conditions – Daily “life saving” feedback from patients – 11-25% Patient response rates within 24 hours – 97% response retention after 18 months*
  6. 6. Patients join by… – REFERRAL through Quintiles’ partner sites – OUTREACH in Quintiles’ clinical clusters – REFERRAL though iGuard’s API partners •Healthcare providers, hospitals, pharmacies •E-Prescribing platforms, PHRs •Patient advocacy groups •Online properties / health portals
  7. 7. Rapid Access to Targeted Patients Feb 10: UK Oct 10: France Germany Spain Australia 8
  8. 8. Improving Research Efficiency
  9. 9. Observational Research – Patient centric studies that collect observational data from patients, physicians, and local laboratories • Phase II/III – Pivotal comparator selection and sample size calculation based on PRO (i.e., new 3rd dimension in addition to safety and efficacy) • Patient-reported outcomes studies – Instrument development/validation – Burden of illness • Observational studies/longitudinal registries • Genomic studies/sample banking • Risk communication/Med Guides (REMS) – Benefit is rapid, cost-effective start-up: • 2 M medically profiled members who have consented to participate in research • Blanket IRB Assessment (also facilitates publication)
  10. 10. For More Information, Please Contact hugo.stephenson@iGuard.org

×